Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: Phase 3 post hoc analyses

Authors

Tara L. Lin, University of Kansas Medical Center
Geoffrey L. Uy, Washington University School of Medicine in St. Louis
et al.

Journal

Blood Advances

Publication Date

2021

Volume

5

Issue

6

First Page

1719

Last Page

1728

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2020003510

Rights and Permissions

Tara L. Lin, David A. Rizzieri, Daniel H. Ryan, Gary J. Schiller, Jonathan E. Kolitz, Geoffrey L. Uy, Donna E. Hogge, Scott R. Solomon, Matthew J. Wieduwilt, Robert J. Ryan, Stefan Faderl, Jorge E. Cortes, Jeffrey E. Lancet; Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: phase 3 post hoc analyses. Blood Adv 2021; 5 (6): 1719–1728. doi: https://doi.org/10.1182/bloodadvances.2020003510

Recommended Citation

Lin, Tara L.; Uy, Geoffrey L.; and al., et, "Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: Phase 3 post hoc analyses." Blood Advances. 5, 6. 1719 - 1728. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10216